Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
deals
life sciences
national blog main
national top stories
boston blog main
boston top stories
fda
new york blog main
boston
frederic moll
johnson & johnson
medical devices
new york
new york top stories
roche
san francisco blog main
ajay royan
alex gorsky
alirocumab
alnylam pharmaceuticals
amgen
ashley mcevoy
auris health
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
detroit
detroit blog main
detroit top stories
duchenne
europe blog main
europe top stories
events
evolocumab
foundation medicine
What
billion
6
×
deal
acquire
cash
medical
agreed
auris
company
fda
medicine
recently
roche
acquiring
adds
ajay
approval
betting
big
biopharma
brings
broad
builds
buy
ceo
cholesterol
come
company’s
compound
confidence
developer
device
didn’t
disrupt
drug
duchenne
entrepreneurs
extremities
foundation
frederic
gain
Language
unset
Current search:
billion
×
biotech
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine